Advanced Research Institute of Multidisciplinary Science, School of Life Science, Beijing Institute of Technology, Beijing, 100081, China.
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology, Beijing, 100190, China.
Angew Chem Int Ed Engl. 2023 Apr 24;62(18):e202214958. doi: 10.1002/anie.202214958. Epub 2023 Mar 8.
Precise regulation of protein activity and localization in cancer cells is crucial to dissect the function of the protein-involved cellular network in tumorigenesis, but there is a lack of suitable methodology. Here we report the design of enzyme-operated spherical nucleic acids (E-SNAs) for manipulation of the nucleocytoplasmic translocation of proteins with cancer-cell selectivity. The E-SNAs are constructed by programmable engineering of aptamer-based modules bearing enzyme-responsive units in predesigned sites and further combination with SNA nanotechnology. We demonstrate that E-SNAs are able to regulate cytoplasmic-to-nuclear shuttling of RelA protein efficiently and specifically in tumor cells, while they remain inactive in normal cells due to insufficient enzyme expression. We further confirmed the generality of this strategy by investigating the enzyme-modulated inhibition/activation of thrombin activity by varying the aptamer-based design.
精确调控癌细胞中蛋白质的活性和定位对于解析肿瘤发生过程中涉及蛋白质的细胞网络的功能至关重要,但目前缺乏合适的方法。在这里,我们报告了酶控球形核酸(E-SNAs)的设计,用于操纵具有癌细胞选择性的蛋白质的核质转运。E-SNAs 通过基于适体的模块的可编程工程构建,这些模块在预先设计的位点带有酶响应单元,并进一步与 SNA 纳米技术结合。我们证明,E-SNAs 能够有效地、特异性地调节肿瘤细胞中 RelA 蛋白的细胞质到细胞核的穿梭,而由于酶表达不足,它们在正常细胞中仍保持不活跃状态。我们通过改变基于适体的设计进一步证实了这种策略的通用性,研究了酶调节的凝血酶活性的抑制/激活。